IL165773A0 - Use of nefopam for the treatment of nausea or emesis - Google Patents

Use of nefopam for the treatment of nausea or emesis

Info

Publication number
IL165773A0
IL165773A0 IL16577304A IL16577304A IL165773A0 IL 165773 A0 IL165773 A0 IL 165773A0 IL 16577304 A IL16577304 A IL 16577304A IL 16577304 A IL16577304 A IL 16577304A IL 165773 A0 IL165773 A0 IL 165773A0
Authority
IL
Israel
Prior art keywords
nefopam
emesis
nausea
treatment
Prior art date
Application number
IL16577304A
Other languages
English (en)
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of IL165773A0 publication Critical patent/IL165773A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/5545—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16577304A 2002-06-17 2004-12-14 Use of nefopam for the treatment of nausea or emesis IL165773A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0213869.1A GB0213869D0 (en) 2002-06-17 2002-06-17 The treatment of pain
PCT/GB2003/002586 WO2003105832A1 (fr) 2002-06-17 2003-06-17 Utilisation de nefopam pour traiter des nausees ou des vomissements

Publications (1)

Publication Number Publication Date
IL165773A0 true IL165773A0 (en) 2006-01-15

Family

ID=9938718

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16577304A IL165773A0 (en) 2002-06-17 2004-12-14 Use of nefopam for the treatment of nausea or emesis

Country Status (15)

Country Link
US (2) US20060040905A1 (fr)
EP (2) EP1513518A1 (fr)
JP (2) JP2005533784A (fr)
CN (1) CN100482221C (fr)
AU (2) AU2003240113B2 (fr)
BR (1) BR0311874A (fr)
CA (2) CA2489306A1 (fr)
GB (1) GB0213869D0 (fr)
IL (1) IL165773A0 (fr)
MX (1) MXPA04012826A (fr)
NO (1) NO20045496L (fr)
NZ (1) NZ537197A (fr)
PL (1) PL374418A1 (fr)
WO (2) WO2003105832A1 (fr)
ZA (1) ZA200410102B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0330049D0 (en) * 2003-12-24 2004-02-04 Arakis Ltd The treatment of neuropathic pain conditions
GB0408864D0 (en) * 2004-04-21 2004-05-26 Arakis Ltd Novel benzoxazocines
GB0515703D0 (en) * 2005-07-29 2005-09-07 Arakis Ltd Therapeutic use of nefopam
WO2009002933A1 (fr) * 2007-06-22 2008-12-31 Hydra Biosciences, Inc. Procédés et compositions pour le traitement de troubles
GB0721013D0 (en) 2007-10-25 2007-12-05 Sosei R & D Ltd New Salts
PT2293794E (pt) 2008-05-27 2013-07-10 Univ Melbourne Métodos de tratamento de mamíferos com disfunções da trompa de eustáquio
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
CN102458400B (zh) 2009-05-20 2014-10-08 国立健康与医学研究所 用于治疗病灶性前庭功能障碍的血清素5-ht3受体拮抗剂
US8957107B2 (en) * 2009-12-15 2015-02-17 The Hospital For Sick Children Method of treating scars and β-catenin-mediated disorders using Nefopam compounds
EP4335508A3 (fr) 2016-04-14 2024-07-10 Sensorion (+)-azasetron destiné à être utilisé dans le traitement de troubles de l'oreille
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
RS65140B1 (sr) * 2019-05-06 2024-02-29 Chemcom Sa Upotreba kompozicije protiv neprijatnih mirisa i povezani postupak

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2234266T3 (es) * 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane

Also Published As

Publication number Publication date
NZ537197A (en) 2007-10-26
AU2003240113A1 (en) 2003-12-31
PL374418A1 (en) 2005-10-17
ZA200410102B (en) 2006-07-26
MXPA04012826A (es) 2005-03-31
JP2005531612A (ja) 2005-10-20
WO2003105833A1 (fr) 2003-12-24
JP2005533784A (ja) 2005-11-10
US20060040905A1 (en) 2006-02-23
AU2003277077A1 (en) 2003-12-31
CA2489306A1 (fr) 2003-12-24
EP1513517A1 (fr) 2005-03-16
NO20045496L (no) 2005-01-12
AU2003277077B2 (en) 2006-11-02
CA2489315A1 (fr) 2003-12-24
EP1513518A1 (fr) 2005-03-16
CN1668294A (zh) 2005-09-14
GB0213869D0 (en) 2002-07-31
AU2003240113B2 (en) 2006-11-16
BR0311874A (pt) 2005-05-10
CN100482221C (zh) 2009-04-29
US20060063753A1 (en) 2006-03-23
WO2003105832A1 (fr) 2003-12-24

Similar Documents

Publication Publication Date Title
AP2006003525A0 (en) Ä1,8ÜNapthyridin-2-ones and related compounds for the treatment of schizophrenia.
HUS2200036I1 (hu) Dihidroimidazolonok alkalmazása kutyák kezelésére
AU2002348135A1 (en) Methods for the treatment of addiction
HK1087103A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
ZA200305691B (en) The use of substituted azetidione compounds for the treatment of sitosterolemia
PT1678185E (pt) Compostos 2,3-di-hidro-6-nitroimidazo[2,1-b]oxazole para o tratamento da tuberculose
HK1072443A1 (en) Immunoconjugates for the treatment of tumours
AU2003217275A1 (en) Azabicyclic compounds for the treatment of disease
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
IL165773A0 (en) Use of nefopam for the treatment of nausea or emesis
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
AP2005003336A0 (en) Combination for the treatment of ADHD
PL377464A1 (pl) Aminoalkoksyindole jako ligandy receptora 5-HT6 do leczenia zaburzeń OUN
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
AU2003205452A1 (en) Bmp inhibitors for the treatment of spondyloarthropathies
HK1080369A1 (zh) 用於治療多發性骨髓瘤的埃博霉素衍生物
IL164951A0 (en) The treatment of pain with lfendropil
AU2003281158A1 (en) The treatment of emesis
GB0317135D0 (en) The treatment of emesis
GB0324208D0 (en) The treatment of emesis
GB0317134D0 (en) The treatment of emesis
GB0413845D0 (en) The treatment of emesis
GB0222948D0 (en) The treatment of emesis,nausea and other disorders
GB0222947D0 (en) The treatment of emesis,nausea and other disorders
GB0216223D0 (en) The treatment of emesis, nausea and other disorders